(S1 (S (S (NP (NP (JJ Physical) (NN association)) (PP (IN of) (NP (DT the) (JJ small) (NN GTPase) (NN Rho))) (PP (IN with) (NP (NP (DT a) (JJ 68-kDa) (NN phosphatidylinositol) (JJ 4-phosphate) (NN 5-kinase)) (PP (IN in) (NP (NN Swiss) (NN 3T3) (NNS cells))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (JJ previous) (NN work)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (ADJP (RB post-translationally) (VBN modified)) (NN Rho)) (PP (IN in) (NP (PRP$ its) (JJ GTP-bound) (NN state)))) (VP (VBD stimulated) (NP (NP (NP (NP (NN phosphatidylinositol) (JJ 4-phosphate) (NN 5-kinase)) (PRN (-LRB- -LRB-) (NP (CD PIP5K)) (-RRB- -RRB-))) (NN activity)) (PP (IN in) (NP (NN mouse) (NN fibroblast) (NNS lysates))))))))) (. .)))
(S1 (S (S (VP (TO To) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN Rho)) (ADVP (RB physically)) (VP (VBZ interacts) (PP (IN with) (NP (NN PIP5K))))))))) (, ,) (NP (PRP we)) (VP (VP (VBD incubated) (NP (VBN immobilized) (NN Rho-GST)) (PP (IN with) (NP (NN Swiss) (NN 3T3) (NN cell) (NNS lysates)))) (CC and) (VP (VBD tested) (PP (IN for) (NP (VBN retained) (NN PIP5K) (NN activity))))) (. .)))
(S1 (S (S (NP (NP (NN Rho-GST)) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NP (NN Ras-GST)) (CC or) (NP (NN GST))) (ADVP (RB alone))) (, ,)) (VP (VBD bound) (NP (JJ significant) (NN PIP5K) (NN activity)))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN binding)) (PP (IN of) (NP (NN PIP5K)))) (VP (VBD was) (ADJP (JJ independent) (PP (IN of) (SBAR (IN whether) (S (NP (NN Rho)) (VP (VBD was) (PP (IN in) (NP (DT a) (ADJP (ADJP (JJ GTP-)) (CC or) (ADJP (JJ GDP-bound))) (NN state)))))))))) (. .)))
(S1 (S (S (NP (NP (DT An) (NN antibody)) (PP (IN against) (NP (NP (DT a) (JJ 68-kDa) (JJ human) (NN erythrocyte) (NN type) (CD I)) (NN PIP5K)))) (VP (VBD recognized) (NP (NP (DT a) (JJ single) (JJ 68-kDa) (NN protein)) (VP (VBN eluted) (PP (IN from) (NP (JJ Rho-GST) (NN column))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ Rho-associated) (NN PIP5K)) (VP (VBD responded) (PP (TO to) (NP (JJ phosphatidic) (NN acid))) (ADVP (ADVP (RB differentially)) (PP (IN from) (NP (DT the) (NN erythrocyte) (NN type) (NN I) (NN PIP5K)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (PRP it)) (VP (MD could) (VP (VB be) (NP (NP (DT a) (JJ distinct) (NN isoform)) (VP (RB not) (VBN reported) (ADVP (RB previously)))))))))))) (. .)))
(S1 (S (S (NP (NN Rho)) (VP (VBN co-immunoprecipitated) (PP (IN with) (NP (NP (DT the) (JJ 68-kDa) (NN PIP5K)) (PP (IN from) (NP (NN Swiss) (NN 3T3) (NNS lysates))))) (, ,) (S (VP (VBG demonstrating) (SBAR (IN that) (S (NP (JJ endogenous) (NN Rho)) (ADVP (RB also)) (VP (VBZ interacts) (PP (IN with) (NP (NN PIP5K)))))))))) (. .)))
(S1 (S (S (NP (NP (NN ADP-ribosylation)) (PP (IN of) (NP (NN Rho))) (PP (IN with) (NP (NN C3) (NN exoenzyme)))) (VP (VBD enhanced) (NP (NN PIP5K) (NN binding)) (PP (IN by) (NP (RB approximately) (RB eightfold))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ ADP-ribosylated) (NN Rho)) (VP (VBG functioning) (PP (IN as) (NP (DT a) (JJ dominant) (JJ negative) (NN inhibitor)))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN Rho)) (ADVP (RB physically)) (VP (VBZ interacts) (PP (IN with) (NP (DT a) (JJ 68-kDa) (NN PIP5K))) (, ,) (SBAR (IN although) (S (SBAR (IN whether) (S (NP (DT the) (NN association)) (VP (VBZ is) (ADJP (ADJP (JJ direct)) (CC or) (ADJP (JJ indirect)))))) (VP (VBZ is) (ADJP (JJ unknown)))))))))) (. .)))
